Key Takeaways:
Two separate class-action lawsuits have been filed against SES AI Corporation (NYSE: SES), alleging the company and its officers made materially false and misleading statements to investors. The lawsuits, brought by law firms Bronstein, Gewirtz & Grossman, LLC and Rosen Law Firm, cover the period between January 29, 2025, and March 4, 2026.
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
The complaints allege that SES AI overstated its business prospects, particularly concerning deals with companies that had limited or no operations. The lawsuits claim SES AI created an "appearance of revenue" by purchasing services in exchange for purchases of its Molecular Universe unit. Furthermore, the suits allege the company failed to disclose significant logistics issues in the fourth quarter of 2025, which materially affected revenue for that period and called its 2026 growth prospects into question.
Investors who purchased SES AI securities during the specified period have until June 26, 2026, to request appointment as lead plaintiff. The lawsuits seek to recover damages for investors who allegedly suffered losses due to the company's purported false statements. Both law firms are representing investors on a contingency fee basis.
The legal proceedings introduce significant uncertainty for SES AI, potentially impacting its stock and financial standing. Investors will be closely watching for the company's official response to the allegations and any subsequent filings in the case. The next major catalyst will be the court's proceedings regarding the appointment of a lead plaintiff.
This article is for informational purposes only and does not constitute investment advice.
